PIPA520683

SPG11 Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA520683-Each-of-1 In Stock ₹ 46,591.50

PIPA520683 - Each of 1

₹ 46,591.50

In Stock

Quantity

1

Base Price: ₹ 46,591.50

GST (18%): ₹ 8,386.47

Total Price: ₹ 54,977.97

Antigen

SPG11

Classification

Polyclonal

Conjugate

Unconjugated

Gene

SPG11

Gene Alias

6030465E24Rik; A330015I11; ALS5; C530005A01Rik; CMT2X; Colorectal carcinoma-associated protein; KIAA1840; RGD1562529; spastic paraplegia 11; spastic paraplegia 11 (autosomal recessive); spastic paraplegia 11 protein; Spastic paraplegia 11 protein homolog; spatacsin; Spg11

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

214585, 311372, 80208

Content And Storage

Maintain refrigerated at 2-8°C for up to 3 months. For long term storage store at -20°C

Form

Liquid

Applications

Immunohistochemistry, Western Blot

Concentration

1 mg/mL

Formulation

PBS with 0.02% sodium azide

Gene Accession No.

Q3UHA3, Q96JI7

Gene Symbols

SPG11

Immunogen

A 15 amino acid synthetic peptide near the carboxy terminus of human SPG11

Quantity

100 μg

Primary or Secondary

Primary

Target Species

Human, Mouse, Rat

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIPA521009

--

Img

Thermo Scientific

PIPA521092

--

Img

Thermo Scientific

PIPA520787

--

Img

Thermo Scientific

PIPA520924

--

Img

Thermo Scientific

PIPA521062

--

Img

Thermo Scientific

PIPA520819

--

Img

Thermo Scientific

PIPA520923

--

Img

Thermo Scientific

PIPA520931

--

Description

  • A suggested positive control is mouse heart tissue lysate
  • PA5-20683 can be used with blocking peptide PEP-0799
  • Hereditary spastic paraplegias (HSPs) are genetically and phenotypically heterogeneous disorders
  • Spastic paraplegia with thinning of the corpus callosum (ARHSP-TCC) is a relatively frequent form of complicated hereditary spastic paraplegia (cHSP) in which mental retardation and muscle stiffness at onset are followed by slowly progressive paraparesis and cognitive deterioration
  • Mutations of the SPG11 gene encoding the spatacsin protein have been identified as a major cause of HSP-TCC
  • Spatacsin is a potential transmembrane protein that is phosphorylated upon DNA damage
  • It is expressed in all structures of the brain, with a high expression in the cerebellum
  • SPG11 mutations may occur more frequently in familial than sporadic forms of cHSP without TCC
  • Kjellin syndrome is found to be associated with mutations in not only the SPG15 gene but also SPG11 gene
  • Recent studies show Parkinsonism may initiate SPG11-linked HSP TCC and that SPG11 may cause juvenile Parkinsonism.